Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedJun 12, 2024
DataAggregated Company Financials
Companies9
  • 7D2.7%
  • 3M33.9%
  • 1Y67.7%
  • YTDn/a

Over the last 7 days, the Pharma industry has risen 1.1%, driven by gains from GlaxoSmithKline Pakistan of 5.6%. This takes the industry's 12 month performance to a gain of 64%. Looking forward, earnings are forecast to grow by 46% annually.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 12 Jun 2024PK₨230.9bPK₨243.6bPK₨8.3b15.4x27.9x0.9x
Fri, 10 May 2024PK₨211.8bPK₨234.6bPK₨9.0b27.5x23.4x0.9x
Sun, 07 Apr 2024PK₨180.2bPK₨227.0bPK₨7.4b25.2x24.3x0.8x
Tue, 05 Mar 2024PK₨171.6bPK₨222.9bPK₨6.3b21.5x27.1x0.8x
Thu, 01 Feb 2024PK₨155.6bPK₨221.2bPK₨6.3b19.4x24.7x0.7x
Sat, 30 Dec 2023PK₨166.3bPK₨221.2bPK₨6.3b20.5x26.4x0.8x
Mon, 27 Nov 2023PK₨170.4bPK₨218.2bPK₨6.2b22.6x27.5x0.8x
Wed, 25 Oct 2023PK₨141.5bPK₨211.7bPK₨6.6b16.5x21.4x0.7x
Fri, 22 Sep 2023PK₨122.7bPK₨209.3bPK₨8.2b12.2x14.9x0.6x
Sun, 20 Aug 2023PK₨136.8bPK₨205.6bPK₨8.7b12.5x15.7x0.7x
Tue, 18 Jul 2023PK₨143.3bPK₨205.6bPK₨8.7b13.1x16.4x0.7x
Thu, 15 Jun 2023PK₨132.0bPK₨205.6bPK₨8.7b12.6x15.1x0.6x
Sat, 13 May 2023PK₨139.3bPK₨195.1bPK₨12.9b11.7x10.8x0.7x
Mon, 10 Apr 2023PK₨139.7bPK₨193.8bPK₨13.7b10x10.2x0.7x
Wed, 08 Mar 2023PK₨144.9bPK₨189.6bPK₨15.2b9.5x9.5x0.8x
Fri, 03 Feb 2023PK₨141.1bPK₨189.4bPK₨15.2b9.2x9.3x0.7x
Sun, 01 Jan 2023PK₨158.9bPK₨189.4bPK₨15.2b10.2x10.4x0.8x
Tue, 29 Nov 2022PK₨183.8bPK₨188.7bPK₨15.0b12.1x12.3x1x
Thu, 27 Oct 2022PK₨194.5bPK₨181.2bPK₨17.2b11.6x11.3x1.1x
Sat, 24 Sep 2022PK₨195.4bPK₨179.3bPK₨18.4b10.9x10.6x1.1x
Mon, 22 Aug 2022PK₨213.8bPK₨169.3bPK₨21.5b10.2x9.9x1.3x
Wed, 20 Jul 2022PK₨212.4bPK₨167.9bPK₨21.4b10.4x9.9x1.3x
Fri, 17 Jun 2022PK₨209.0bPK₨165.2bPK₨21.4b9.3x9.8x1.3x
Sun, 15 May 2022PK₨214.0bPK₨163.7bPK₨21.2b9.4x10.1x1.3x
Tue, 12 Apr 2022PK₨224.4bPK₨161.9bPK₨21.1b10.5x10.6x1.4x
Thu, 10 Mar 2022PK₨224.3bPK₨160.8bPK₨19.7b11.1x11.4x1.4x
Sat, 05 Feb 2022PK₨243.5bPK₨160.5bPK₨20.0b11.6x12.2x1.5x
Mon, 03 Jan 2022PK₨244.3bPK₨160.5bPK₨20.0b11.6x12.2x1.5x
Wed, 01 Dec 2021PK₨249.4bPK₨160.5bPK₨20.0b12.2x12.5x1.6x
Fri, 29 Oct 2021PK₨264.2bPK₨157.2bPK₨19.8b13.2x13.3x1.7x
Sun, 26 Sep 2021PK₨268.9bPK₨153.6bPK₨18.7b13.8x14.4x1.8x
Tue, 24 Aug 2021PK₨281.0bPK₨153.6bPK₨18.7b13.7x15x1.8x
Wed, 30 Jun 2021PK₨272.6bPK₨148.4bPK₨18.4b13.6x14.8x1.8x
Price to Earnings Ratio

14.8x


Total Market Cap: PK₨272.6bTotal Earnings: PK₨18.4bTotal Revenue: PK₨148.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 15.3x202220232024
Current Industry PE
  • Investors are optimistic on the Pakistani Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 27.9x which is higher than its 3-year average PE of 15.3x.
  • The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.95x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 23% per year over the last three years.
  • Meanwhile revenues for these companies have grown 18% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Pakistani Pharma compare with similar industries?

PK Market-3.03%
Healthcare2.37%
Pharma2.66%
Pharma2.66%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GLAXO GlaxoSmithKline PakistanPK₨128.235.8%
+PK₨2.2b
65.3%PE61.1x
AGP AGPPK₨84.294.6%
+PK₨1.0b
65.3%PE14.7x
HPL Hoechst PakistanPK₨1.50k7.1%
+PK₨964.5m
107.0%PE13.7x
SEARL SearlePK₨58.132.8%
+PK₨808.2m
38.8%PS0.8x
FEROZ Ferozsons LaboratoriesPK₨239.845.4%
+PK₨529.9m
73.4%PE21.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SEARL

PK₨58.13

Searle

7D

2.8%

1Y

38.8%

FEROZ

PK₨239.84

Ferozsons Laboratories

7D

5.4%

1Y

73.4%

HPL

PK₨1,500.00

Hoechst Pakistan

7D

7.1%

1Y

107.0%

HINOON

PK₨693.67

Highnoon Laboratories

7D

1.4%

1Y

88.9%

AGP

PK₨84.29

AGP

7D

4.6%

1Y

65.3%

CPHL

PK₨27.71

Citi Pharma

7D

-1.0%

1Y

22.4%

GLAXO

PK₨128.23

GlaxoSmithKline Pakistan

7D

5.8%

1Y

65.3%

ABOT

PK₨680.04

Abbott Laboratories (Pakistan)

7D

0.7%

1Y

75.1%

OTSU

PK₨112.79

Otsuka Pakistan

7D

-4.4%

1Y

52.4%